Issued Patents All Time
Showing 76–100 of 143 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6093540 | Method for diagnosing a disorder characterized by expression of a BAGE tumor rejection antigen precursor | Pierre van der Bruggen, Pierre Coulie, Jean-Christophe Renauld | 2000-07-25 |
| 6069001 | Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof | Benoit Van den Eynde, Olivier DeBacker | 2000-05-30 |
| 6063900 | Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof | Cornelis Joseph Maria Melief, Marjan J. W. Visseren, W. Martin Kast, Pierre van der Bruggen | 2000-05-16 |
| 6060257 | Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof | Jean Herman, Pierre Coulie, Pierre van der Bruggen, Immanuel F. Luescher | 2000-05-09 |
| 6027924 | Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof | Sophie Lucas, Charles De Smet | 2000-02-22 |
| 6025474 | Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof | Benoit Van den Eynde, Pierre van den Bruggen | 2000-02-15 |
| 6022692 | Method for screening for possible presence of cancer | Pierre Coulie, Hideyuki Ikeda | 2000-02-08 |
| 6019987 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Pierre van der Bruggen, Catia Traversari, Katharina Fleischauer | 2000-02-01 |
| 6017705 | Isolated nucleic acid molecules which are members of the MAGE-B family and uses thereof | Christophe Lurquin, Francis Brasseur | 2000-01-25 |
| 6013765 | Isolated tumor rejection antigens derived from DAGE tumor rejection antigen precusor | Pierre Coulie, Hideyuki Ikeda | 2000-01-11 |
| 6013481 | Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof | Olivier DeBacker, Benoit Van den Eynde | 2000-01-11 |
| 6001975 | Precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas Wolfel, Etienne De Plaen | 1999-12-14 |
| 5997872 | Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof | Sophie Lucas, Charles De Smet | 1999-12-07 |
| 5997870 | Isolated peptides which bind to HLA-B44 Molecules | Pierre Coulie | 1999-12-07 |
| 5985571 | Method for determining multiple myeloma by assaying for expression of mage genes | Nicolas Van Baren, Francis Brasseur | 1999-11-16 |
| 5977300 | Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof | Jean Herman, Pierre Coulie, Pierre van der Bruggen | 1999-11-02 |
| 5965535 | Mage-3 peptides presented by HLA class II molecules | Pascal Chaux, Vincent Stroobant, Pierre van der Bruggen | 1999-10-12 |
| 5965381 | Delivery of proteins into eukaryotic cells with recombinant yersinia | Pierre van der Bruggen, Guy R. Cornelis, Anne M. Boland | 1999-10-12 |
| 5958711 | Methods for determining expression of NAG tumor rejection antigen precursor | Yannick Guilloux, Francine Jotereau, Sophie Lucas, Vincent Brichard | 1999-09-28 |
| 5955313 | Nucleic acid molecule encoding a bifunctional protein, the protein so encoded uses thereof | Pierre van der Bruggen, Susanna Mandruzzato | 1999-09-21 |
| 5952468 | Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof | Pierre van der Bruggen | 1999-09-14 |
| 5952228 | Isolated cytolytic T cells which are specific for complexes OF HLA- B35 molecules and the peptide PHE Pro Ser Asp Ser Trp Cys Tyr PHE, and uses thereof | Pierre van der Bruggen, Susanna Mandruzzato | 1999-09-14 |
| 5939526 | Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof | Beatrice Gaugler, Benoit Van den Eynde, Peter Schrier, Nathalie Brouwenstijn | 1999-08-17 |
| 5932694 | Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof | Pierre van der Bruggen, Susanna Mandruzzato | 1999-08-03 |
| 5928938 | Isolated peptides which complex with HLA-Cw*16 molecules, and uses thereof | Pierre van der Bruggen, Etienne DePlaen | 1999-07-27 |